Abstract |
Cancer cells often develop multidrug resistance (MDR) which is a multidimensional problem involving several mechanisms and targets. This study demonstrates that chelidonine and an alkaloid extract from Chelidonium majus, which contains protoberberine and benzo[c]phenanthridine alkaloids, has the ability to overcome MDR of different cancer cell lines through interaction with ABC-transporters, CYP3A4 and GST, by induction of apoptosis, and cytotoxic effects. Chelidonine and the alkaloid extract inhibited P-gp/MDR1 activity in a concentration-dependent manner in Caco-2 and CEM/ADR5000 and reversed their doxorubicin resistance. In addition, chelidonine and the alkaloid extract inhibited the activity of the drug modifying enzymes CYP3A4 and GST in a dose-dependent manner. The alkaloids induced apoptosis in MDR cells which was accompanied by an activation of caspase-3, -8,-6/9, and phosphatidyl serine (PS) exposure. cDNA arrays were applied to identify differentially expressed genes after treatment with chelidonine and the alkaloid extract. The expression analysis identified a common set of regulated genes related to apoptosis, cell cycle, and drug metabolism. Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA. Thus, chelidonine is a promising model compound for overcoming MDR and for enhancing cytotoxicity of chemotherapeutics, especially against leukaemia cells. Its efficacy needs to be confirmed in animal models.
|
Authors | Mahmoud Zaki El-Readi, SafaaYehia Eid, Mohamed Lotfy Ashour, Ahmad Tahrani, Michael Wink |
Journal | Phytomedicine : international journal of phytotherapy and phytopharmacology
(Phytomedicine)
Vol. 20
Issue 3-4
Pg. 282-94
(Feb 15 2013)
ISSN: 1618-095X [Electronic] Germany |
PMID | 23238299
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
|
Copyright | Crown Copyright © 2012. Published by Elsevier GmbH. All rights reserved. |
Chemical References |
- ATP-Binding Cassette Transporters
- Alkaloids
- Antibiotics, Antineoplastic
- Benzophenanthridines
- Cytochrome P-450 CYP3A Inhibitors
- Drugs, Chinese Herbal
- Plant Extracts
- Doxorubicin
- chelidonine
- Cytochrome P-450 CYP3A
- CYP3A4 protein, human
- Glutathione Transferase
- Caspases
|
Topics |
- ATP-Binding Cassette Transporters
(antagonists & inhibitors)
- Alkaloids
(chemistry)
- Antibiotics, Antineoplastic
- Apoptosis
(drug effects)
- Benzophenanthridines
(pharmacology)
- Caspases
(metabolism)
- Cell Line, Tumor
- Chelidonium
(chemistry)
- Chromatography, Liquid
- Cytochrome P-450 CYP3A
- Cytochrome P-450 CYP3A Inhibitors
- Doxorubicin
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Drug Screening Assays, Antitumor
- Drug Synergism
- Drugs, Chinese Herbal
(pharmacology)
- Enzyme Activation
(drug effects)
- Gene Expression Profiling
- Glutathione Transferase
(antagonists & inhibitors)
- Humans
- Mass Spectrometry
- Oligonucleotide Array Sequence Analysis
- Plant Extracts
(chemistry)
- Real-Time Polymerase Chain Reaction
|